Try it
General Medicine · Neurology: idiopathic intracranial hypertension
Sample itemA 27-year-old obese woman has daily headaches worse on lying down, transient visual obscurations and bilateral papilloedema. MRI and MR venography are normal and lumbar puncture shows an opening pressure of 38 cm of CSF with normal composition. What is the first-line drug to add to weight loss?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Acetazolamide
Idiopathic intracranial hypertension typically affects obese women of childbearing age and threatens vision through papilloedema. Weight loss and acetazolamide, a carbonic anhydrase inhibitor that reduces CSF production, are first-line. Shunting or optic nerve sheath fenestration is reserved for progressive visual loss despite medical therapy.
Option by option
A. Oral prednisolone
Steroids are not recommended, cause weight gain and can worsen the condition on withdrawal.
B. Acetazolamide (correct)
Correct. Acetazolamide lowers CSF production and protects vision.
C. Immediate optic nerve sheath fenestration
Surgery is held back for failed medical therapy or rapidly deteriorating vision.
D. Propranolol
Propranolol can be used for headache prevention but does not lower intracranial pressure.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…